Research / AMD / Fundamental state Inspectable configuration
State dimensions Filing 0000002488-26-000076 General Corporate
Debt relative to revenue 69th Own-history percentile · N=13
Evidence method Level · gp.fundamentals.debt_to_revenue
31.44% · OPTIONAL · VALID
Capex intensity 100th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
3.79% · OPTIONAL · VALID
Operating cash generation 100th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
28.82% · OPTIONAL · VALID
Revenue growth 65th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
37.85% · CORE · VALID
Inventory pressure 60th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
78.46% · OPTIONAL · VALID
Gross margin 100th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
52.82% · CORE · VALID
Operating margin 75th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
14.40% · CORE · VALID
R&D intensity 55th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
23.38% · OPTIONAL · VALID
SBC intensity 45th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
4.75% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 35 states Self-history eligible
Sep 25, 2021 8/8 normalized Level 3 Dec 25, 2021 8/9 normalized Level 3 Mar 26, 2022 8/8 normalized Level 3 Jun 25, 2022 8/8 normalized Level 3 Sep 24, 2022 8/8 normalized Level 3 Dec 31, 2022 8/8 normalized Level 3 Apr 1, 2023 8/8 normalized Level 3 Jul 1, 2023 8/9 normalized Level 3 Sep 30, 2023 8/9 normalized Level 3 Dec 30, 2023 8/8 normalized Level 3 Mar 30, 2024 8/9 normalized Level 3 Jun 29, 2024 9/9 normalized Level 3 Sep 28, 2024 9/9 normalized Level 3 Dec 28, 2024 9/9 normalized Level 3 Mar 29, 2025 8/8 normalized Level 3 Jun 28, 2025 8/8 normalized Level 3 Sep 27, 2025 9/9 normalized Level 3 Dec 27, 2025 9/9 normalized Level 3 Mar 28, 2026 9/9 normalized Level 3 Jun 27, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 11.82%
Current 31.44%
Delta 19.62% Capex Intensity Increased
Previous 2.81%
Current 3.79%
Delta 0.98% Cash Generation Increased
Previous 22.26%
Current 28.82%
Delta 6.57% Growth Increased
Previous 34.34%
Current 37.85%
Delta 3.51% Inventory Pressure Increased
Previous 22.86%
Current 78.46%
Delta 55.60% Margin Increased
Previous 49.52%
Current 52.82%
Delta 3.31% Profitability Increased
Previous 10.66%
Current 14.40%
Delta 3.73% R And D Intensity Increased
Previous 23.36%
Current 23.38%
Delta 0.02% Sbc Intensity Increased
Previous 4.73%
Current 4.75%
Delta 0.02% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.